logo
Analysts Offer Insights on Healthcare Companies: US Physical Therapy (USPH) and Barinthus Biotherapeutics (BRNS)

Analysts Offer Insights on Healthcare Companies: US Physical Therapy (USPH) and Barinthus Biotherapeutics (BRNS)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on US Physical Therapy (USPH – Research Report) and Barinthus Biotherapeutics (BRNS – Research Report).
Protect Your Portfolio Against Market Uncertainty
Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
US Physical Therapy (USPH)
In a report released today, Ryan Daniels from William Blair reiterated a Hold rating on US Physical Therapy. The company's shares closed last Wednesday at $70.96.
According to TipRanks.com, Daniels is a 4-star analyst with an average return of 7.7% and a 49.6% success rate. Daniels covers the Healthcare sector, focusing on stocks such as Definitive Healthcare Corp, Lifestance Health Group, and Pediatrix Medical Group.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for US Physical Therapy with a $108.25 average price target.
Barinthus Biotherapeutics (BRNS)
In a report released today, Andy Hsieh from William Blair reiterated a Buy rating on Barinthus Biotherapeutics. The company's shares closed last Wednesday at $0.99, close to its 52-week low of $0.80.
According to TipRanks.com, Hsieh is a 4-star analyst with an average return of 6.0% and a 43.7% success rate. Hsieh covers the Healthcare sector, focusing on stocks such as Structure Therapeutics, Inc. Sponsored ADR, Corbus Pharmaceuticals, and Terns Pharmaceuticals.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Barinthus Biotherapeutics with a $4.50 average price target.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Mineral Resources Limited (MALRF) Gets a Hold from Macquarie
Mineral Resources Limited (MALRF) Gets a Hold from Macquarie

Business Insider

time4 days ago

  • Business Insider

Mineral Resources Limited (MALRF) Gets a Hold from Macquarie

Macquarie analyst Robert Stein maintained a Hold rating on Mineral Resources Limited (MALRF – Research Report) on June 27 and set a price target of A$22.00. The company's shares closed last Friday at $13.60. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Stein covers the Basic Materials sector, focusing on stocks such as Mineral Resources Limited, Champion Iron, and Iluka Resources Limited. According to TipRanks, Stein has an average return of -2.0% and a 45.39% success rate on recommended stocks. In addition to Macquarie, Mineral Resources Limited also received a Hold from Citi's Kate McCutcheon in a report issued on June 20. However, on June 24, Morgans maintained a Buy rating on Mineral Resources Limited (Other OTC: MALRF).

Aurelia Metals (AUMTF) Receives a Buy from Macquarie
Aurelia Metals (AUMTF) Receives a Buy from Macquarie

Business Insider

time4 days ago

  • Business Insider

Aurelia Metals (AUMTF) Receives a Buy from Macquarie

Macquarie analyst Adam Baker maintained a Buy rating on Aurelia Metals (AUMTF – Research Report) on June 27 and set a price target of A$0.27. The company's shares closed last Wednesday at $0.13. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Baker covers the Basic Materials sector, focusing on stocks such as Aurelia Metals , Sandfire Resources Limited, and FireFly Metals. According to TipRanks, Baker has an average return of -16.4% and a 45.24% success rate on recommended stocks. Aurelia Metals has an analyst consensus of Strong Buy, with a price target consensus of $0.20, a 50.72% upside from current levels. In a report released on June 25, Jefferies also maintained a Buy rating on the stock with a A$0.28 price target.

Macquarie Sticks to Its Buy Rating for IGO (IPGDF)
Macquarie Sticks to Its Buy Rating for IGO (IPGDF)

Business Insider

time4 days ago

  • Business Insider

Macquarie Sticks to Its Buy Rating for IGO (IPGDF)

Macquarie analyst Robert Stein maintained a Buy rating on IGO (IPGDF – Research Report) on June 27 and set a price target of A$4.50. The company's shares closed last Tuesday at $2.75. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Stein is an analyst with an average return of -2.0% and a 45.39% success rate. Stein covers the Basic Materials sector, focusing on stocks such as Mineral Resources Limited, Champion Iron, and Iluka Resources Limited. IGO has an analyst consensus of Hold, with a price target consensus of $2.76. The company has a one-year high of $4.40 and a one-year low of $1.99. Currently, IGO has an average volume of 917.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store